{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:07:57Z","timestamp":1793333277630,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1245\/s10434-020-09465-8","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T21:13:14Z","timestamp":1609621994000},"page":"4647-4654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned"],"prefix":"10.1245","volume":"28","author":[{"given":"W. J.","family":"Koemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Houwink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"van der Kaaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C. E.","family":"Wassenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Boerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Ari\u00ebns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A. F. A.","family":"Veenhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. J.","family":"Hartemink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"van Sandick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"9465_CR1","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426\u201332.","journal-title":"Ann Surg Oncol."},{"key":"9465_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ Van Driel","year":"2018","unstructured":"Van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, et al. (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378: 230\u201340.","journal-title":"N Engl J Med."},{"key":"9465_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104\u20139.","journal-title":"Ann Surg."},{"key":"9465_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14:183.","journal-title":"BMC Cancer."},{"key":"9465_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12885-019-5640-2","volume":"19","author":"WJ Koemans","year":"2019","unstructured":"Koemans WJ, van der Kaaij RT, Boot H, Buffart T, Veenhof A, Hartemink KJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination: the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer. 2019;19:420.","journal-title":"BMC Cancer."},{"key":"9465_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","volume":"23","author":"B Rau","year":"2020","unstructured":"Rau B, Brandl A, Piso P, Pelz J, Busch P, Demtroder C, et al. Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2020;23:11\u201322.","journal-title":"Gastric Cancer."},{"key":"9465_CR7","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.ejso.2018.06.036","volume":"44","author":"C Rihuete Caro","year":"2018","unstructured":"Rihuete Caro C, Manzanedo I, Pereira F, Carrion-Alvarez L, Serrano A, Perez-Viejo E. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. Eur J Surg Oncol. 2018;44:1805\u201310.","journal-title":"Eur J Surg Oncol."},{"key":"9465_CR8","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028\u201340.","journal-title":"J Clin Oncol."},{"key":"9465_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jso.22017","volume":"104","author":"RS Gill","year":"2011","unstructured":"ill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, Schiller D. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol. 2011;104:692\u20138.","journal-title":"J Surg Oncol."},{"key":"9465_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/tgh.2016.07.03","volume":"1","author":"Z Wu","year":"2016","unstructured":"Wu Z, Li Z, Ji J. Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Transl Gastroenterol Hepatol. 2016;1:63.","journal-title":"Transl Gastroenterol Hepatol."},{"key":"9465_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","volume":"43","author":"C Raspe","year":"2017","unstructured":"Raspe C, Flother L, Schneider R, Bucher M, Piso P. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol. 2017;43:1013\u201327.","journal-title":"Eur J Surg Oncol."},{"key":"9465_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1213\/ANE.0b013e3182860fff","volume":"116","author":"CA Webb","year":"2013","unstructured":"Webb CA, Weyker PD, Moitra VK, Raker RK. An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist. Anesth Analg. 2013;116:924\u201331.","journal-title":"Anesth Analg."},{"key":"9465_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1477-7819-9-169","volume":"9","author":"TJ Cooksley","year":"2011","unstructured":"Cooksley TJ, Haji-Michael P. Postoperative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2011;9:169.","journal-title":"World J Surg Oncol."},{"key":"9465_CR14","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1245\/s10434-012-2496-y","volume":"19","author":"JC Bell","year":"2012","unstructured":"Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19:4244\u201351.","journal-title":"Ann Surg Oncol."},{"key":"9465_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/089686080802800111","volume":"28","author":"F De Somer","year":"2008","unstructured":"De Somer F, Ceelen W, Delanghe J, De Smet D, Vanackere M, Pattyn P, Mortier E. Severe hyponatremia, hyperglycemia, and hyperlactatemia are associated with intraoperative hyperthermic intraperitoneal chemoperfusion with oxaliplatin. Perit Dial Int. 2008;28:61\u20136.","journal-title":"Perit Dial Int."},{"key":"9465_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s13193-016-0511-7","volume":"7","author":"AV Padmakumar","year":"2016","unstructured":"Padmakumar AV. Intensive care management of patient after cytoreductive surgery and HIPEC: a concise review. Indian J Surg Oncol. 2016;7:244\u20138.","journal-title":"Indian J Surg Oncol."},{"key":"9465_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2196\/resprot.7790","volume":"6","author":"RT van der Kaaij","year":"2017","unstructured":"van der Kaaij RT, Braam HJ, Boot H, Los M, Cats A, Grootscholten C, et al. Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): rationale and design of the PERISCOPE study. JMIR Res Protoc. 2017;6:136.","journal-title":"JMIR Res Protoc."},{"key":"9465_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11588","author":"RT van der Kaaij","year":"2020","unstructured":"van der Kaaij RT, Wassenaar ECE, Koemans WJ, Sikorska K, Grootscholten C, Los M, et al. Treatment of PERItoneal disease in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): initial results of the PERISCOPE I. Br J Surg. 10.1002\/bjs.11588 2020.","journal-title":"Br J Surg."},{"key":"9465_CR19","unstructured":"ClinicalTrials.gov. Identifier: NCT03348150. Gastrectomy\u2009+\u2009cytoreductive surgery\u2009+\u2009HIPEC for gastric cancer with peritoneal dissemination. (PERISCOPE II). Retrieved 1 January 2020 at https:\/\/ClinicalTrials.gov\/show\/NCT03348150"},{"key":"9465_CR20","unstructured":"U.S. Department of Health and Human Services NCI. Common terminology criteria for adverse events (CTCAE). 2009; https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf."},{"key":"9465_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ajcn\/40.1.168","volume":"40","author":"AM Roza","year":"1984","unstructured":"Roza AM, Shizgal HM. The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am J Clin Nutr. 1984;40:168\u201382.","journal-title":"Am J Clin Nutr."},{"key":"9465_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249:900\u20137.","journal-title":"Ann Surg."},{"key":"9465_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/02656736.2017.1354133","volume":"34","author":"NB Shannon","year":"2018","unstructured":"Shannon NB, Tan GHC, Chia CS, Soo KC, Teo MC. Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Int J Hyperthermia. 2018;34:518\u201323.","journal-title":"Int J Hyperthermia."},{"key":"9465_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3389\/fimmu.2018.00663","volume":"9","author":"GP Leijte","year":"2018","unstructured":"Leijte GP, Custers H, Gerretsen J, Heijne A, Roth J, Vogl T, et al. Increased plasma levels of danger-associated molecular patterns are associated with immune suppression and postoperative infections in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Front Immunol. 2018;9:663.","journal-title":"Front Immunol."},{"key":"9465_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0002-8223(98)00179-5","volume":"98","author":"CJ Klein","year":"1998","unstructured":"Klein CJ, Stanek GS, Wiles CE III. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc. 1998;98:795\u2013806.","journal-title":"J Am Diet Assoc."},{"key":"9465_CR26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/jim-2016-000083","volume":"64","author":"XF Zhao","year":"2016","unstructured":"Zhao XF, Wu N, Zhao GQ, Liu JF, Dai YF. Enteral nutrition versus parenteral nutrition after major abdominal surgery in patients with gastrointestinal cancer: a systematic review and meta-analysis. J Investig Med 2016;64:1061\u201374.","journal-title":"J Investig Med"},{"key":"9465_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1213\/00000539-199405000-00018","volume":"78","author":"N Shime","year":"1994","unstructured":"Shime N, Lee M, Hatanaka T. Cardiovascular changes during continuous hyperthermic peritoneal perfusion. Anesth Analg. 1994;78:938\u201342.","journal-title":"Anesth Analg."},{"key":"9465_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2044.2007.05380.x","volume":"63","author":"C Schmidt","year":"2008","unstructured":"Schmidt C, Creutzenberg M, Piso P, Hobbhahn J, Bucher M. Perioperative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 2008;63:389\u201395.","journal-title":"Anaesthesia."},{"key":"9465_CR29","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/CCM.0000000000001567","volume":"44","author":"BC Creagh-Brown","year":"2016","unstructured":"Creagh-Brown BC, De Silva AP, Ferrando-Vivas P, Harrison DA. Relationship between peak lactate and patient outcome following high-risk gastrointestinal surgery: influence of the nature of their surgery: elective versus emergency. Crit Care Med. 2016;44:918\u201325.","journal-title":"Crit Care Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09465-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T16:08:32Z","timestamp":1625242112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9465"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09465-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"25 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}